Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), is pleased to announce that the company's wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR"), a licenced producer under the Cannabis Act, has received a research licence from Health Canada effective April 11, 2022. The licence allows THR to evaluate the ingredients produced by the proprietary APP technology and product formulations incorporating these ingredients.

"We are pleased to receive this license since we can now evaluate our proprietary extracts and the unique 2.0 product formulations before moving them forward to manufacturing and sale to Canadian consumers." said Arup Sen, CEO & Director.

Northern Ontario has the highest rates of cannabis dependence in high-school students across the province, according to the study Drug use among Ontario Students, published by the Canadian Mental Health Association in 2020.

When a group of fourth-year medical students at NOSM University learned these statistics, they felt compelled to educate preteens and teenagers ages 12-18 as part of their unique advocacy curriculum.

“Our goal with this project was to create a captivating, information-packed video to educate youth about cannabis and share harm reduction strategies using reliable resources from the Canadian Paediatric Society (CPS) and the Government of Canada,” says Kelsey Pitre, fourth-year NOSM University medical student.

Agra Ventures Ltd, a growth-oriented and diversified company focused on the international cannabis industry, applauds Health Canada’s recently announced regulatory changes that will have the effect of streamlining the application process for cannabis processors to bring products to market more quickly. On March 31, 2022, Health Canada communicated that it would begin granting all standard and micro-class processing license holders sales authorizations for dried and fresh cannabis products during the initial licensing process. Therefore, licensees such as AGRA will no longer have to apply for an amendment in order to sell to wholesalers. The planned improvements to the licensing process are scheduled to go into effect on April 19, 2022.

The pandemic saw a boom in legal recreational cannabis sales across Canada. From March 2020 to February 2021, sales totaled $2.5 billion, double the $1.25 billion of the previous 12 months. Surveys likewise reported more cannabis users and more frequent usage in 2020 than the year before.

The increases were often blamed, despite a lack of evidence, on the COVID-19 pandemic and related societal disruptions. Many people were stuck alone at home and feeling stressed. Some commentators later walked back their claims after it became clear there was no data to support them, but the narrative still persists.

Although it’s a compelling anecdote, our new research found that the growth in cannabis sales was more likely from industry expansion, rather than the pandemic.

Legal grow-ops to be licensed and moved into manufacturing or industrial areas

The City of Winnipeg is closing a pair of loopholes that allow medical cannabis grow-ops to sprout up in homes in quiet residential neighbourhoods.

City council's property committee voted unanimously Tuesday to approve bylaw changes that will require Health Canada-approved medical cannabis production facilities to operate within industrial or manufacturing areas.

In a parallel move next week, council's protection committee will consider a report that will require medical cannabis growing operations to be licensed and inspected by the city and pay fines for violating those licences.

THC stored in fat cells gradually diffuse into the bloods. Regardless, the rate of diffusion increases under circumstances that promote fat utilization, such as exercising and fasting.

Tetrahydrocannabinol (THC) accumulates in fat tissue and can stay there for months. Although this can serve as a barrier to those who face frequent testing, athletes may take delight in the results of exuding THC from the fat in their bodies.

The news comes on the heels of the company launch by Dr. Richard van Breemen, a researcher with Oregon State's Global Hemp Innovation Center, College of Pharmacy and Linus Pauling Institute yet more famously for discovering that certain cannabinoid acids in hemp can prevent and treat coronavirus infection. 

Short-term exposure may cause health effects such as eye, nose, throat and lung irritation, coughing, sneezing, runny nose and shortness of breath

Some people continue to maintain that second-hand cannabis smoke (SHCS) poses no risk, but a new study out of the U.S. begs to differ.

New York State’s Department of Health reports that particles in the PM2.5 size range “are able to travel deeply into the respiratory tract, reaching the lungs.”

The World Health Organization is looking into claims of hearing loss after people receive their COVID-19 vaccine. Here’s what we know.

The World Health Organization (WHO) is looking into hearing issues as a sequel of COVID-19 vaccines. The organization announced they’d be looking into the issue in a recent newsletter posted on its website.

According to the newsletter, the organization has learned of a variety of hearing issues that people all over the world have reported following their COVID-19 shots. These issues include tinnitus, hearing loss, or sudden changes in people’s hearing habits.